spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  MaxCyte 

 HSMN NewsFeed - 28 Mar 2022
Avenge Bio Appoints Claudio Dansky Ullmann, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Jul 2020
APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 7 May 2020
Caribou Biosciences and MaxCyte Enter into Clinical and Commercial License Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 Mar 2020
MaxCyte and Allogene Therapeutics Sign Clinical and Commercial License Agreement to Enable the Advancement of Allogeneic CAR T (AlloCAR T(TM)) Therapies
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 19 Dec 2019
MaxCyte Appoints New Executive Vice President, Business Development for CARMA(TM) Cellular Therapies and Provides Clinical Trial Update
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Nov 2018
Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 25 Apr 2018
MaxCyte Appoints Dr. Claudio Dansky Ullmann as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Aug 2017
MaxCyte Appoints Executive Vice President of Global Marketing
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Sep 2011
Rib-X Announces Senior Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Apr 2011
Novavax Announces Change in Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Dec 2006
United Therapeutics Affiliate Initiates First-Ever Gene-Therapy Trial for Pulmonary Arterial Hypertension
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 12 Dec 2006
Northern Therapeutics and MaxCyte Initiate Landmark Engineered Cell Therapy Trial for Fatal Lung Disease
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 13 Sep 2006
MaxCyte Strengthens Leadership Team
Regenerative Medicine Personnel
Return to NewsFeed  

 Additional items found! 7

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 7 additional stories matching:
MaxCyte
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.